PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $914,424 | -25.4% | 148,929 | -24.0% | 0.00% | – |
| Q2 2023 | $1,226,440 | -72.4% | 195,917 | -79.0% | 0.00% | – |
| Q1 2023 | $4,444,199 | -49.7% | 931,698 | -8.2% | 0.00% | -100.0% |
| Q4 2022 | $8,832,380 | +56.5% | 1,015,216 | +114.0% | 0.00% | 0.0% |
| Q3 2022 | $5,645,000 | -8.6% | 474,371 | +9.5% | 0.00% | 0.0% |
| Q2 2022 | $6,176,000 | +15.5% | 433,326 | +68.7% | 0.00% | 0.0% |
| Q1 2022 | $5,347,000 | +213.4% | 256,837 | +247.9% | 0.00% | – |
| Q4 2021 | $1,706,000 | +112.2% | 73,819 | +173.7% | 0.00% | – |
| Q3 2021 | $804,000 | -41.2% | 26,969 | -32.6% | 0.00% | – |
| Q2 2021 | $1,367,000 | +7.3% | 40,019 | +3.3% | 0.00% | – |
| Q1 2021 | $1,274,000 | +366.7% | 38,746 | +771.5% | 0.00% | – |
| Q4 2020 | $273,000 | +2381.8% | 4,446 | +1382.0% | 0.00% | – |
| Q3 2020 | $11,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |